Amvis : Q2Financial Highlights （1,507KB）

First Half Ended March 31, 2023

Business and Financial Highlights

Amvis Holdings, Inc.

May 15, 2023

©Amvis Holdings, Inc.

Table of Contents

1

2

３

4

FY23 1H Financial Results Summary

Achieving Our Medium- to Long-Term Growth

Appendix

Company Overview

©Amvis Holdings, Inc.	2

Establishing Sustainable Mechanisms and Businesses through Which We Can Address Social Problems

Social Problem-Solving Business

Acceptance

of

Patients

Opening of		Provision of
New		Necessary
Facilities	Social	Medical Care
	Problem-
	solving

ProfitabilityOperational

ImprovementImprovements

Under the government's policy of shortening of hospital stays and returning home, Ishinkan has been actively accepting patients who are unsure of where to go after being discharged from medical facilities, including those in the terminal stages of cancer, those who need respiratory care (are on respirators, have had tracheostomies, etc.), and those with neurodegenerative diseases. Meanwhile, we have remained conscious of our role as an organization that supports the successful functioning of regional healthcare and have endeavored to fulfill this role by, in principle, ensuring that patients can continue to be seen by their existing primary physicians and care managers.

In order to satisfy our duty to support regional healthcare, we aim to further expand the Ishinkan business. Also, we plan to focus more on strengthening and revitalizing regional healthcare by providing various support for exhausted medical institutions and care providers, utilizing the know-how and human resources acquired through the Ishinkan business.

We hope our business will help to solve the medical problems of revitalizing regional healthcare, reducing the exhaustion of medical workers, and alleviating regional disparities in healthcare and to enhance the medical and care system, which is the goal of the government.

©Amvis Holdings, Inc.	3

Highlights

Changed market listing to the Prime market of the Tokyo Stock Exchange

• On March 14, 2023, we listed on the Prime market, the top market of the Tokyo Stock Exchange, in an attempt to expand the investor base both in Japan and overseas.

1  Due to the secondary offering by major shareholders implemented at the time of the change of market listing, stock liquidity has improved significantly, with daily trading volume exceeding JPY 1.0bn.

In addition to the development in Eastern Japan, centered on the Tokyo metro area, decided to expand into the Kansai area for the first time

• We have already decided to open 7 new facilities in Tokyo during FY23 and FY24 1H, accelerating the

2	formation of dominant areas in Tokyo and its metro area.

• Due to strong demand, in addition to expanding the existing facilities (Ishinkan Hachinohe and Ishinkan Mito), we have decided to open Ishinkan Toyonaka (Osaka prefecture, 75 beds), our first facility in Kansai area, in July 2024.

	Accelerating the development of Ishinkan, which mainly accepts patients in terminal stage of cancer
		We transferred the business of Ishinkan Yokkaichi, which targeted patients in the chronic stage of illness, to
3		another care provider on March 1, 2023.
	We actively develop Ishinkan, which mainly accepts patients who are in the terminal stages of illness such as

terminal cancer or those with high medical dependency and face difficulty in being accepted at other facilities, and provide responsible care until the end of their lives.

©Amvis Holdings, Inc.	4

Steady Progress as Expected Despite the Impact of COVID-19

FY23	1H Operating Performance
1H Net Sales (Actual)			1H Operating Profit (Actual)

JPY 14.7bn	JPY 3.9bn
(Operating margin: 26.7%)

Full-Year Net Sales (Forecast)		Full-Year Operating Profit (Forecast)

JPY 30.6bn	JPY 7.8bn
(Progress toward full-year	(Progress toward full-year
forecast: 48.0%)	forecast: 50.0%)

©Amvis Holdings, Inc.	5